Class II
Terminated
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healt…
Why: cGMP Deviations
- Company
- Unexo Life Sciences Private Limited
New Delhi, India - Reported
- Dec 4, 2024
- Recall started
- Oct 24, 2024
- Ended
- Sep 16, 2025
- Where sold
- Nationwide in the US
- Amount
- 455,536 patches
- Full product description
- THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031
- Lots / codes affected
- a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.